Spire Wealth Management - VISTAGEN THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 117 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.91 and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Spire Wealth Management ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$1,0000.0%600
-40.0%
0.00%–
Q1 2022$1,000
-50.0%
1,000
+25.0%
0.00%–
Q4 2021$2,0000.0%800
+33.3%
0.00%–
Q3 2021$2,000–600–0.00%–
 Download
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Performa Ltd (US), LLC 4,900$9,1630.01%
View complete list of VISTAGEN THERAPEUTICS INC shareholders